Nimbus

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

admin January 11, 2026 0

-- New collaboration follows previous Lilly and Nimbus AMPK research collaboration in cardiometabolic disease -- BOSTON, January 06, 2026--(BUSINESS WIRE)--Nimbus...

United States – Goodwin Represents Nimbus Therapeutics In Research Collaboration And License Agreement With Lilly For Novel Oral Obesity Treatment For Up To $1.3 Billion

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

IEEE Course Improves Technical Writing Skills

DVIDS – News – A new era of maritime excellence: an update on the Mariner Skills Training Centers

Build AI skills: Google AI Professional Certificate

Crossroads Barrie Answers Canada’s Professional Driver Shortage with Versatile Driver Training Programs

IPB University and Simon Fraser University Discuss Research Collaboration, Double Degree, and Student Mobility

United States – Goodwin Represents Nimbus Therapeutics In Research Collaboration And License Agreement With Lilly For Novel Oral Obesity Treatment For Up To $1.3 Billion

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

You may have missed

IEEE Course Improves Technical Writing Skills

DVIDS – News – A new era of maritime excellence: an update on the Mariner Skills Training Centers

Build AI skills: Google AI Professional Certificate

Crossroads Barrie Answers Canada’s Professional Driver Shortage with Versatile Driver Training Programs

IPB University and Simon Fraser University Discuss Research Collaboration, Double Degree, and Student Mobility